BeOne Medicines
ONC
#660
Rank
A$53.10 B
Marketcap
A$479.92
Share price
-2.39%
Change (1 day)
47.93%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Net assets

Net assets on the balance sheet as of September 2025 : A$6.21 Billion

According to BeOne Medicines's latest financial reports the company has A$6.21 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BeOne Medicines - Net assets on balance sheet (from 2014 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$5.35 B3.18%
2023-12-31$A$5.19 B-19.4%
2022-12-31$A$6.44 B-23.85%
2021-12-31$A$8.45 B68.1%
2020-12-31$A$5.03 B260.1%
2019-12-31$A$1.39 B-43.86%
2018-12-31$A$2.48 B184.03%
2017-12-31$A$0.87 B79.01%
2016-12-31$A$0.48 B379.9%
2015-12-31$A$0.10 B224.01%
2014-12-31$A$31.48 M-172.52%
2013-12-31$-A$43.42 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Onconova Therapeutics
ONTX
A$9.05 M-99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
A$1.96 B-68.38%๐Ÿ‡บ๐Ÿ‡ธ USA